<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="3522">
  <stage>Registered</stage>
  <submitdate>12/04/2012</submitdate>
  <approvaldate>12/04/2012</approvaldate>
  <nctid>NCT01580566</nctid>
  <trial_identification>
    <studytitle>Renal Acute MI Study</studytitle>
    <scientifictitle>Renal Structural, Functional and Cytokine Responses to Acute Myocardial Injury in Man</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>CP-03/11</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Myocardial Infarction</healthcondition>
    <healthcondition>Kidney Function</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Coronary heart disease</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Other cardiovascular diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Group 1 - Control - Non-Q wave MI subjects with normal cardiac and renal function (defined as eGFR &gt;60ml/min) not undergoing a cardiac procedure involving contrast will serve as "control" for renal injury subjects.

Group 2 - stable CAD or non-Q wave MI - Patients undergoing coronary angiography +/- PCI for stable CAD or non-Q wave MI with normal cardiac and renal function (defined as eGFR &gt;60ml/min) will control for the contrast STEMI patients are likely to receive as part of their post-MI management

Group 3 - Acute STEMI without chronic kidney disease - Acute STEMI patients (n=40), without chronic kidney disease (defined as eGFR =60ml/min).

Group 4 - Acute STEMI with kidney disease - Acute STEMI patients (n=40), with evidence of background chronic kidney disease (eGFR &lt;60ml/min).

</interventions>
    <comparator />
    <control />
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>changes in renal function and structure</outcome>
      <timepoint>Baseline, discharge, 1 month, 6 months and 12 months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>renal response to myocardial infarction</outcome>
      <timepoint>baseline, discharge, 1 month, 6 months and 12 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Age &gt; 18 years

        Have provided written informed consent

        Group 1:

          -  Non-Q wave MI patients

          -  normal cardiac and renal function

          -  No use of contrast

          -  eGFR &gt; 60ml/min

        Group 2:

          -  Patients undergoing coronary angiography +/- PCI for stable CAD or non-Q wave MI

          -  normal cardiac and renal function

          -  eGFR &gt; 60ml/min

        Group 3:

          -  Acute STEMI Full thickness infarct (STEMI)

          -  eGFR = 60ml/min

        Group 4:

          -  Acute STEMI Full thickness infarct (STEMI)

          -  eGFR &lt; 60ml/min</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Unable or unwilling to comply with the study protocol

          -  Underlying medical condition which, in the opinion of the investigator, will effect
             the safely or efficacy of the study</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/03/2012</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>160</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>1/12/2018</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>Alfred Hospital - Melbourne</hospital>
    <postcode>3004 - Melbourne</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Monash University</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to determine if a sizable myocardial infarction (heart attack)
      results in negative changes to renal structure and function (i.e. has a negative impact on
      the kidneys).

      To determine if the renal response to a myocardial infarction is a predictor of the patients
      future health.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT01580566</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Henry Krum, MBBS FRACP PhD</name>
      <address>Alfred Hospital/Monash.University</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>Henry Krum, MBBS FRACP PhD</name>
      <address />
      <phone>+613 9903 0042</phone>
      <fax />
      <email>henry.krum@monash.edu</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>